Aarhus University logo

    • About
      • About the Nordic EMBL Partnership
      • Mission statement
      • EMBL non-tenure model
      • Contact
    • News
    • Collaborations
      • NORPOD - Postdoctoral Researcher Programme
      • NordForsk: Nordic EMBL Partnership Hub
      • How the Nordic EMBL Partnership is helping to fight COVID-19
      • Tools of the Trade Data Science Webinar Series
      • Nordic EMBL Partnership Meetings
      • Nordic EMBL Partnership Science and Art
    • Research
    • Technologies
    • Training
    • Careers
    • Internal

    Read more

    Click here to read more

    DANDRITE

    The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership, and performs basic and translational research in brain and the nervous system.

    FIMM

    The Institute for Molecular Medicine Finland (FIMM) is the Finnish node of the Nordic EMBL Partnership. FIMM’s research interests are human genomics and personalized medicine, with a focus on translational research.

    MIMS

    The Laboratory for Molecular Infection Medicine Sweden (MIMS) is the Swedish node of the Nordic EMBL Partnership. MIMS aims to strengthen Swedish research and enhance the dynamics in the field of molecular medicine.

    NCMBM

    The Norwegian Centre for Molecular Biosciences and Medicine (NCMBM) is the Norwegian node of the Nordic EMBL Partnership. NCMBM conducts molecular medicine & biotech research and works to translate these findings into clinical practice. 

    News from the Partnership


    Malaria researchers at MIMS, Ellen Bushell and Oliver Billker, reflect on World Malaria Day (25 April)

    23 April 2021 - Research news

    During the World Health Assembly in 2007, the World Health Organization (WHO) Member States established 25th April as World Malaria Day. Fourteen…

    Three NCMM research groups extended for a further four years

    20 April 2021 - People

    Following a successful evaluation by NCMM’s Scientific Advisory Board (SAB), the NCMM Board has decided to extend the groups of Irep Gözen, Nikolina…

    Immune cells out of control: how lethal hyperinflammation emerges from a novel gene defect

    19 April 2021 - Research news

    An international research team has discovered a novel subtype of a genetic immune deficiency disease. A genetically determined deficiency of the…

    New perspectives for treating psychiatric disorders

    08 April 2021 - Research news

    Scientists at DANDRITE and EMBL Hamburg have determined the structure of Glycine Transporter 1. The finding could open new avenues for developing…

    Page 50 of 70.

    • Previous
    • 1
    • …
    • 49
    • 50
    • 51
    • …
    • 70
    • Next

    Upcoming Partnership Events


    No events found.

    Follow us!

    Follow us for the latest updates and insights! Join our community and stay connected with us on the following platforms

    LinkedIn
    Bluesky
    X

     

    About 

    News 

    Collaborations

    Research

    Technologies

    Training

    Careers

     

     

     

    Follow us

    X: @NordicEMBL

    LinkedIn: linkedin.com/company/nordic-embl-partnership-for-molecular-medicine

     

    The Nordic EMBL Partnership for Molecular Medicine combines the complementary research expertise of the Nordic countries with a common aim to address some of the biggest challenges in biomedicine today.

     

    Revised 21.03.2025

    © — Cookies at au.dk
    Privacy Policy
    Accessibility Statement

    15450 / i43